{"id":543141,"date":"2021-05-13T13:58:01","date_gmt":"2021-05-13T13:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=543141"},"modified":"2021-05-13T13:58:01","modified_gmt":"2021-05-13T13:58:01","slug":"dravet-syndrome-ds-market-analysis-market-size-epidemiology-leading-companies-and-therapies-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dravet-syndrome-ds-market-analysis-market-size-epidemiology-leading-companies-and-therapies-delveinsight_543141.html","title":{"rendered":"Dravet Syndrome (DS) Market Analysis, Market Size, Epidemiology, Leading Companies And Therapies | DelveInsight"},"content":{"rendered":"
\"Dravet<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cDravet Syndrome (DS) \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u2033 report delivers an in-depth understanding of the Dravet Syndrome (DS), historical and forecasted epidemiology as well as the Dravet Syndrome (DS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

DelveInsight has launched a new report on “Dravet Syndrome (DS) – Market Insights, Epidemiology, and Market Forecast-2030<\/strong><\/p>\n

DelveInsight’s “Dravet Syndrome (DS) – Market Insights, Epidemiology, and Market Forecast-2030<\/strong><\/a>″ report delivers an in-depth understanding of the Dravet Syndrome (DS), historical and forecasted epidemiology as well as the Dravet Syndrome (DS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. \n

    As per DelveInsight’s estimates, the total incident population of Dravet Syndrome in the 7 major markets was 36,301 in 2017<\/p>\n<\/li>\n

  2. \n

    As per DelveInsight’s estimates, the United States accounted for the maximum number of DS patients with 20,731 cases in 2017 followed by Germany with 2,896 cases<\/p>\n<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

    1. Dravet Syndrome (DS) market report covers a descriptive overview and comprehensive insight of the Dravet Syndrome (DS) epidemiology and Dravet Syndrome (DS) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/p>\n

    2. The Dravet Syndrome (DS) market report provides insights on the current and emerging therapies.<\/p>\n

    3. Dravet Syndrome (DS) market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n

    4. The Dravet Syndrome (DS) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Dravet Syndrome (DS) market.<\/p>\n

    Request for sample pages: https:\/\/www.delveinsight.com\/sample-request\/dravet-syndrome-market<\/span><\/a>
    <\/a><\/strong><\/p>\n

    Dravet Syndrome (DS): Overview<\/strong><\/p>\n

    Dravet syndrome (DS) is a severe form of epilepsy characterized by frequent, prolonged seizures often triggered by high body temperature (hyperthermia), developmental delay, speech impairment, ataxia, hypotonia, sleep disturbances, and other health problems.<\/p>\n

    The key players involved in Dravet Syndrome (DS) market<\/a>:<\/strong><\/p>\n

      \n
    1. \n

      Biocodex<\/p>\n<\/li>\n

    2. \n

      GW Pharmaceuticals<\/p>\n<\/li>\n<\/ol>\n

      The launch of the emerging therapies is expected to significantly impact the  Dravet Syndrome (DS) treatment scenario in the upcoming years:-<\/strong><\/p>\n

      Drug covered<\/strong><\/p>\n

        \n
      1. \n

        Diacomit<\/p>\n<\/li>\n

      2. \n

        Epidiolex<\/p>\n<\/li>\n<\/ol>\n

        Request a free sample report @https:\/\/www.delveinsight.com\/sample-request\/dravet-syndrome-market<\/span><\/a><\/strong><\/p>\n

        Table of Contents<\/strong><\/p>\n

        1. Report Introduction<\/p>\n

        2. Executive Summary<\/p>\n

        3. SWOT analysis<\/p>\n

        4. Dravet Syndrome (DS) Patient Share (%) Overview at a Glance<\/p>\n

        5. Dravet Syndrome (DS) Market Overview at a Glance<\/p>\n

        6. Dravet Syndrome (DS) Disease Background and Overview<\/p>\n

        7. Dravet Syndrome (DS) Epidemiology and Patient Population<\/p>\n

        8. Country-Specific Patient Population of Dravet Syndrome (DS)<\/p>\n

        9. Dravet Syndrome (DS) Current Treatment and Medical Practices<\/p>\n

        10. Unmet Needs<\/p>\n

        11. Dravet Syndrome (DS) Emerging Therapies<\/p>\n

        12. Dravet Syndrome (DS) Market Outlook<\/p>\n

        13. Country-Wise Dravet Syndrome (DS) Market Analysis (2017–2030)<\/p>\n

        14. Market Access and Reimbursement of Therapies<\/p>\n

        15. Market drivers<\/p>\n

        16. Market barriers<\/p>\n

        17. Appendix<\/p>\n

        18. Dravet Syndrome (DS) Report Methodology<\/p>\n

        19. DelveInsight Capabilities<\/p>\n

        20. Disclaimer<\/p>\n

        21. About DelveInsight<\/p>\n

        Related Reports:<\/p>\n

        Dravet Syndrome- Pipeline Insights, 2021<\/p>\n

        “Dravet Syndrome (DS) Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Dravet Syndrome (DS) market. A detailed picture of the  Dravet Syndrome (DS) pipeline landscape is provided, which includes the disease overview and Dravet Syndrome (DS) treatment guidelines.<\/p>\n

        Dravet Syndrome (DS) – Epidemiology Forecast to 2030<\/p>\n

        DelveInsight’s ‘Dravet Syndrome (DS) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dravet Syndrome (DS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n

        Media Contact<\/span>
        Company Name:<\/strong>         DelveInsight Business Research LLP<\/a>
        Contact Person:<\/strong> Kritika Rehani
        Email:<\/strong>         Send Email<\/a>
        Phone:<\/strong> 9193216187
        Address:<\/strong>304 S. Jones Blvd #2432
        City:<\/strong> Las Vegas
        State:<\/strong> Nevada
        Country:<\/strong> United States
        Website:<\/strong>         https:\/\/www.delveinsight.com\/<\/a><\/p>\n

        <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

        DelveInsight Business Research LLP DelveInsight\u2019s \u201cDravet Syndrome (DS) \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u2033 report delivers an in-depth understanding of the Dravet Syndrome (DS), historical and forecasted epidemiology as well as the Dravet Syndrome (DS) market trends in the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-543141","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/543141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=543141"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/543141\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=543141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=543141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=543141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}